Q32 Bio Inc. (QTTB) Dividend History
Income profile from 2016 to 2025 with payout safety and yield-on-cost trend
QTTB Dividend Income Check
Safety
Payout ratio data not available yet.
Consistency
0 straight years of dividend increases.
Income Trend
Yield on cost trend needs more history.
QTTB Dividend Scorecard
Yield & Income
Payout Safety
Growth
Total Returns
Uses precomputed total return metrics from screening data (not lot-by-lot dividend reinvestment transactions). QTTB's recent 5Y regime has been stronger than its full 10Y period, so 5Y can appear higher than 10Y.
QTTB Dividend History
No dividend payment history available
Get QTTB's next ex-dividend date and payout in your inbox
Monthly dividend calendar — upcoming ex-dates for stocks you follow.
Dividend Analysis
Payout Safety
Q32 Bio Inc. has limited earnings payout data (Unknown).
Piotroski F-Score: 4/9 — moderate financial health.
Growth Track Record
QTTB does not have a current streak of consecutive dividend increases.
Total Shareholder Returns
Beyond cash dividends, QTTB returns capital through share repurchases. The combined picture: 0.0% total shareholder yield.
Income Trend & Total Return
The 5-year total return is -90.2%.
DRIP Growth
A $10,000 investment made 10 years ago with dividends reinvested would have grown to approximately $378 today.
QTTB Dividend vs Peers
Comparable companies in the same industry
QTTB Annual Dividend History (2016–2025)
10 years of dividend data
| Year | DPS | YoY | Pmts | EPS | Payout | Coverage | YOC |
|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | — | 0 | $2.42 | — | — | — |
| 2024 | $0.00 | — | 0 | $-6.58 | — | — | — |
| 2023 | $0.00 | — | 0 | $-16.70 | — | — | — |
| 2022 | $0.00 | — | 0 | $-13.42 | — | — | — |
| 2021 | $0.00 | — | 0 | $-31.18 | — | — | — |
| 2020 | $0.00 | — | 0 | $-50.46 | — | — | — |
| 2019 | $0.00 | — | 0 | $-44.41 | — | — | — |
| 2018 | $0.00 | — | 0 | $-35.04 | — | — | — |
| 2017 | $0.00 | — | 0 | $-14.42 | — | — | — |
| 2016 | $0.00 | — | 0 | $-3.87 | — | — | — |
What if you invested $1,000 in QTTB back in 2016?
Total return with dividends reinvested · 10+ years of data
Calculate ReturnsHow much would $100/month in QTTB be worth today?
Dollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersIs QTTB Undervalued Right Now?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationQTTB vs LLY — which is the better buy?
Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.
Compare NowQTTB — Frequently Asked Questions
Quick answers to the most common questions about buying QTTB stock.
How much dividend does QTTB pay per share?
Q32 Bio Inc. (QTTB) pays a trailing 12-month dividend of N/A per share, with a current dividend yield of N/A. Payments are made quarterly.
When is QTTB's next ex-dividend date?
QTTB's most recent ex-dividend date is N/A. You must own shares before the ex-dividend date to receive the next payment. QTTB typically pays dividends quarterly.
Is QTTB's dividend safe?
QTTB's dividend safety is rated "Unknown" based on an earnings payout ratio of N/A and FCF payout ratio of N/A. The dividend history does not yet show a prolonged growth streak.
How many years has QTTB increased its dividend?
QTTB has not maintained a consecutive growth streak recently. The 5-year dividend CAGR is N/A.
How often does QTTB pay dividends?
Q32 Bio Inc. pays dividends quarterly. The trailing 12-month total is N/A per share. Dividend data on this page covers 9+ years from 2016 to 2025.
How much would $10,000 invested in QTTB grow with dividend reinvestment?
With dividends reinvested (DRIP), $10,000 invested in QTTB five years ago would be worth approximately $984 today. This includes both price appreciation and compounded dividend reinvestment. Use the DRIP calculator above for other time periods.
What is QTTB's yield on cost for long-term holders?
QTTB's yield on cost — the current dividend divided by the original purchase price — is N/A for a 5-year holding period. This means long-term holders earn a higher effective yield than today's N/A market yield, thanks to the lower original cost basis.